Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsORALStandard

LISDEXAMFETAMINE DIMESYLATE

LISDEXAMFETAMINE DIMESYLATE

Standard Dose
50MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview LISDEXAMFETAMINE DIMESYLATE is listed in Drugs@FDA under application 218987 (ANDA).

Review priority: STANDARD Marketing status: Prescription Active ingredient LISDEXAMFETAMINE DIMESYLATE Form and strength CAPSULE;ORAL - 50MG Sponsor GRANULES Submission history Latest submission status date: 2025-01-29 00:00:00.

Structured Monograph

Clinical summary

Approval overview LISDEXAMFETAMINE DIMESYLATE is listed in Drugs@FDA under application 218987 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient LISDEXAMFETAMINE DIMESYLATE Form and strength CAPSULE;ORAL - 50MG Sponsor GRANULES Submission history Latest submission status date: 2025-01-29 00:00:00. Submission type: ORIG.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.